Alten stock declines more than 6% over one month ahead of Friday earnings
The engineering and technology consulting group is approaching the publication of its first-half 2026 results under pressure, with a decline in trading as European markets themselves move into negative territory. The stock ranks 97th in the SBF 120, in an index that is also losing ground this Thursday.
A session decline that brings the stock back below its twenty-day moving average
Alten loses 1.93% to €71.20 in trading, slipping slightly below its 20-day MA at €71.80 (gap of -0.84%). The stock nonetheless remains above its 50-day MA at €70.57 and nearly 10% above its 200-day MA at €64.78, which testifies to a medium-term anchor that remains positive. The RSI at 55 stays in neutral territory, without particular signals of exhaustion in either direction.
Resistance at €76.90 and support at €66.10 delimit the current technical framework. Over one month, the stock declines 6.38%, but it still displays a gain of over 30% on a three-month basis, a legacy of the strong summer rebound documented in the increases at the end of August. The trading context is unfavorable: European markets are retreating this Thursday, against a backdrop of rising bond yields that weigh on valuations of growth stocks.
2026 half-year results expected tomorrow, valuation to watch based on consensus
The next appointment is already on everyone's mind: Alten's 2026 half-year results are expected this Friday, September 25th. The publication will come after a marked rebound in the stock between June and late August, followed by a return to favor last Monday after several weeks of turbulence that had brought the price below its support level of €68.35. According to the consensus of surveyed analysts, the stock is trading at around 9.5 times the expected earnings for the current fiscal year and 8.4 times those for the following fiscal year, with earnings per share growth projected at +12.5% from one fiscal year to the next.
Furthermore, the group has repurchased €46 million of its own shares over twelve months (latest statement read as of September 16, 2026), representing 1.8% of market capitalization, which constitutes structural support for the stock. The first-half results, expected tomorrow, will be the first concrete test of the profit trajectory on which this valuation rests.
